Learn more

BIOPROJET SOC CIV

Overview
  • Total Patents
    384
  • GoodIP Patent Rank
    29,259
  • Filing trend
    ⇧ 2400.0%
About

BIOPROJET SOC CIV has a total of 384 patent applications. It increased the IP activity by 2400.0%. Its first patent ever was published in 1981. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are CONN P JEFFREY, BIAL PORTELA & CA SA and SUVEN LIFE SCIENCES LTD.

Patent filings per year

Chart showing BIOPROJET SOC CIVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lecomte Jeanne-Marie 281
#2 Schwartz Jean-Charles 278
#3 Robert Philippe 147
#4 Ligneau Xavier 146
#5 Capet Marc 145
#6 Levoin Nicolas 99
#7 Berrebi-Bertrand Isabelle 97
#8 Danvy Denis 68
#9 Labeeuw Olivier 58
#10 Calmels Thierry 56

Latest patents

Publication Filing date Title
BR102018073582A2 ENANTIOMER, PROCESS OF PREPARATION OF AN ENANTIOMER, USE OF THE ENANTIOMER, PHARMACEUTICAL COMPOSITION AND COMBINATION
EP3598975A1 Novel combinations of a h3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof
EP3378858A1 Tetrahydrate of h3 ligand, its process of preparation and pharmaceutical compositions comprising the same
AU2013326470A1 A combination of adrenalin with an antidepressant for use in the treatment of shocks
EP2671883A1 New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands
EP2671870A1 Novel (aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications
EP2511275A1 Novel piperidinyl monocarboxylic acids as S1P1 receptor agonists
EP2462922A1 New form of administration of enkephalinase inhibitor
EP2447263A1 Benzazole derivatives as histamine H4 receptor ligands
EP2263672A1 Novel pharmaceutically acceptable salts of 4-(1H-imidazol-4-ylmethyl)pyridine and their therapeutical uses
CA2659754A1 Combination of modafinil and an antagonist or inverse agonist of the h3 receptor
EP2014653A1 Novel dicarboxylic acid derivatives as S1P1 receptor agonists
CN101442990A New form of administration of racecadotril
TW200736238A Process for preparing 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine
EP1870405A1 Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands
FR2902009A1 Use of a vasopeptidase inhibitor for the treatment of pulmonary arterial hypertension
US2008214542A1 Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands
EP1659112A1 Arylpiperazuine derivatives as selective ligand for the dopamine D3 receptor
EP1717235A2 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
EP1717233A1 Histamine H3-receptor ligands and their therapeutic application